Defining the biological basis of radiomic phenotypes in lung cancer

Patrick Grossmann, Olya Stringfield, Nehme El-Hachem, Marilyn M. Bui, Emmanuel Rios Velazquez, Chintan Parmar, Ralph T. H. Leijenaar, Benjamin Haibe-Kains, Philippe Lambin, Robert J. Gilles, Hugo J. W. L. Aerts*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number23421
Number of pages22
JournalElife
Volume6
DOIs
Publication statusPublished - 21 Jul 2017

Keywords

  • GENE-EXPRESSION DATA
  • INTRATUMOR HETEROGENEITY
  • TUMOR PHENOTYPE
  • TEXTURE ANALYSIS
  • PROBE LEVEL
  • STAGE-I
  • FEATURES
  • SURVIVAL
  • CT
  • GLIOBLASTOMA

Cite this

Grossmann, P., Stringfield, O., El-Hachem, N., Bui, M. M., Velazquez, E. R., Parmar, C., ... Aerts, H. J. W. L. (2017). Defining the biological basis of radiomic phenotypes in lung cancer. Elife, 6, [23421]. https://doi.org/10.7554/eLife.23421
Grossmann, Patrick ; Stringfield, Olya ; El-Hachem, Nehme ; Bui, Marilyn M. ; Velazquez, Emmanuel Rios ; Parmar, Chintan ; Leijenaar, Ralph T. H. ; Haibe-Kains, Benjamin ; Lambin, Philippe ; Gilles, Robert J. ; Aerts, Hugo J. W. L. / Defining the biological basis of radiomic phenotypes in lung cancer. In: Elife. 2017 ; Vol. 6.
@article{806c716977da469ba7656c319e79ddac,
title = "Defining the biological basis of radiomic phenotypes in lung cancer",
keywords = "GENE-EXPRESSION DATA, INTRATUMOR HETEROGENEITY, TUMOR PHENOTYPE, TEXTURE ANALYSIS, PROBE LEVEL, STAGE-I, FEATURES, SURVIVAL, CT, GLIOBLASTOMA",
author = "Patrick Grossmann and Olya Stringfield and Nehme El-Hachem and Bui, {Marilyn M.} and Velazquez, {Emmanuel Rios} and Chintan Parmar and Leijenaar, {Ralph T. H.} and Benjamin Haibe-Kains and Philippe Lambin and Gilles, {Robert J.} and Aerts, {Hugo J. W. L.}",
year = "2017",
month = "7",
day = "21",
doi = "10.7554/eLife.23421",
language = "English",
volume = "6",
journal = "Elife",
issn = "2050-084X",
publisher = "eLife Sciences Publications, Ltd",

}

Grossmann, P, Stringfield, O, El-Hachem, N, Bui, MM, Velazquez, ER, Parmar, C, Leijenaar, RTH, Haibe-Kains, B, Lambin, P, Gilles, RJ & Aerts, HJWL 2017, 'Defining the biological basis of radiomic phenotypes in lung cancer', Elife, vol. 6, 23421. https://doi.org/10.7554/eLife.23421

Defining the biological basis of radiomic phenotypes in lung cancer. / Grossmann, Patrick; Stringfield, Olya; El-Hachem, Nehme; Bui, Marilyn M.; Velazquez, Emmanuel Rios; Parmar, Chintan; Leijenaar, Ralph T. H.; Haibe-Kains, Benjamin; Lambin, Philippe; Gilles, Robert J.; Aerts, Hugo J. W. L.

In: Elife, Vol. 6, 23421, 21.07.2017.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Defining the biological basis of radiomic phenotypes in lung cancer

AU - Grossmann, Patrick

AU - Stringfield, Olya

AU - El-Hachem, Nehme

AU - Bui, Marilyn M.

AU - Velazquez, Emmanuel Rios

AU - Parmar, Chintan

AU - Leijenaar, Ralph T. H.

AU - Haibe-Kains, Benjamin

AU - Lambin, Philippe

AU - Gilles, Robert J.

AU - Aerts, Hugo J. W. L.

PY - 2017/7/21

Y1 - 2017/7/21

KW - GENE-EXPRESSION DATA

KW - INTRATUMOR HETEROGENEITY

KW - TUMOR PHENOTYPE

KW - TEXTURE ANALYSIS

KW - PROBE LEVEL

KW - STAGE-I

KW - FEATURES

KW - SURVIVAL

KW - CT

KW - GLIOBLASTOMA

U2 - 10.7554/eLife.23421

DO - 10.7554/eLife.23421

M3 - Article

VL - 6

JO - Elife

JF - Elife

SN - 2050-084X

M1 - 23421

ER -

Grossmann P, Stringfield O, El-Hachem N, Bui MM, Velazquez ER, Parmar C et al. Defining the biological basis of radiomic phenotypes in lung cancer. Elife. 2017 Jul 21;6. 23421. https://doi.org/10.7554/eLife.23421